Kidney bioengineering in regenerative medicine: An emerging therapy for kidney disease

Cytotherapy. 2016 Feb;18(2):186-97. doi: 10.1016/j.jcyt.2015.10.004. Epub 2015 Dec 1.

Abstract

The prevalence of end-stage renal disease is emerging as a serious worldwide public health problem because of the shortage of donor organs and the need to take lifelong immunosuppressive medication in patients who receive a transplanted kidney. Recently, tissue bioengineering of decellularization and recellularization scaffolds has emerged as a novel strategy for organ regeneration, and we review the critical technologies supporting these methods. We present a summary of factors associated with experimental protocols that may shed light on the future development of kidney bioengineering and we discuss the cell sources and bioreactor techniques applied to the recellularization process. Finally, we review some artificial renal engineering technologies and their future prospects, such as kidney on a chip and the application of three-dimensional and four-dimensional printing in kidney tissue engineering.

Keywords: extracellular matrix; kidney decellularization; kidney recellularization; regenerative medicine; tissue engineering.

Publication types

  • Research Support, Non-U.S. Gov't
  • Review

MeSH terms

  • Animals
  • Bioreactors
  • Guided Tissue Regeneration / methods*
  • Humans
  • Induced Pluripotent Stem Cells / cytology
  • Kidney / cytology
  • Kidney / pathology
  • Kidney Failure, Chronic / therapy*
  • Organogenesis
  • Rats
  • Regeneration*
  • Regenerative Medicine / trends*
  • Tissue Engineering / methods*
  • Tissue Scaffolds